BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26196739)

  • 1. The Orphan Nuclear Receptor TLX Is an Enhancer of STAT1-Mediated Transcription and Immunity to Toxoplasma gondii.
    Beiting DP; Hidano S; Baggs JE; Geskes JM; Fang Q; Wherry EJ; Hunter CA; Roos DS; Cherry S
    PLoS Biol; 2015 Jul; 13(7):e1002200. PubMed ID: 26196739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Releasing the Brake on IFN-γ Signaling on Infection.
    Lüder CGK; Sumpf K; Nast R
    Trends Parasitol; 2015 Oct; 31(10):456-459. PubMed ID: 26422772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma Effector Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block IFN-γ-Dependent Gene Expression.
    Olias P; Etheridge RD; Zhang Y; Holtzman MJ; Sibley LD
    Cell Host Microbe; 2016 Jul; 20(1):72-82. PubMed ID: 27414498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii Inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA.
    Rosowski EE; Nguyen QP; Camejo A; Spooner E; Saeij JP
    Infect Immun; 2014 Feb; 82(2):706-19. PubMed ID: 24478085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii stabilises tetrameric complexes of tyrosine-phosphorylated signal transducer and activator of transcription-1 and leads to its sustained and promiscuous DNA binding.
    Nast R; Staab J; Meyer T; Lüder CGK
    Cell Microbiol; 2018 Nov; 20(11):e12887. PubMed ID: 29968354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ.
    Lang C; Hildebrandt A; Brand F; Opitz L; Dihazi H; Lüder CG
    PLoS Pathog; 2012 Jan; 8(1):e1002483. PubMed ID: 22275866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.
    Hidano S; Randall LM; Dawson L; Dietrich HK; Konradt C; Klover PJ; John B; Harris TH; Fang Q; Turek B; Kobayashi T; Hennighausen L; Beiting DP; Koshy AA; Hunter CA
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activity.
    Schneider AG; Abi Abdallah DS; Butcher BA; Denkers EY
    PLoS One; 2013; 8(3):e60215. PubMed ID: 23527309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning up STAT1.
    Sedwick C
    PLoS Biol; 2015 Jul; 13(7):e1002201. PubMed ID: 26196960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses.
    Gay G; Braun L; Brenier-Pinchart MP; Vollaire J; Josserand V; Bertini RL; Varesano A; Touquet B; De Bock PJ; Coute Y; Tardieux I; Bougdour A; Hakimi MA
    J Exp Med; 2016 Aug; 213(9):1779-98. PubMed ID: 27503074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFNγ induced gene expression and STAT1 phosphorylation.
    Rosowski EE; Saeij JP
    PLoS One; 2012; 7(12):e51448. PubMed ID: 23240025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.
    Fluhr H; Seitz T; Zygmunt M
    Breast Cancer Res Treat; 2013 Jan; 137(1):109-18. PubMed ID: 23160925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors.
    Del Rio L; Butcher BA; Bennouna S; Hieny S; Sher A; Denkers EY
    J Immunol; 2004 Jun; 172(11):6954-60. PubMed ID: 15153515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.
    Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR
    Front Immunol; 2019; 10():1253. PubMed ID: 31231385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling.
    Zimmermann S; Murray PJ; Heeg K; Dalpke AH
    J Immunol; 2006 Feb; 176(3):1840-7. PubMed ID: 16424215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Shimizu T; Tada Y; Watanabe S
    Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
    Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
    Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis.
    Lieberman LA; Banica M; Reiner SL; Hunter CA
    J Immunol; 2004 Jan; 172(1):457-63. PubMed ID: 14688355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.